Annemette Thougaard

1.6k total citations
30 papers, 1.2k citations indexed

About

Annemette Thougaard is a scholar working on Molecular Biology, Oncology and Small Animals. According to data from OpenAlex, Annemette Thougaard has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Oncology and 4 papers in Small Animals. Recurrent topics in Annemette Thougaard's work include Cancer Treatment and Pharmacology (6 papers), Computational Drug Discovery Methods (4 papers) and Cancer therapeutics and mechanisms (4 papers). Annemette Thougaard is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Computational Drug Discovery Methods (4 papers) and Cancer therapeutics and mechanisms (4 papers). Annemette Thougaard collaborates with scholars based in Denmark, Singapore and Austria. Annemette Thougaard's co-authors include Maxwell Sehested, Peter Buhl Jensen, Helle Stege, Flemming Bager, E Jacobsen, Jorrit J. Hornberg, Tomas Mow, Jette Tjørnelund, Mikael Persson and Uffe H. Olesen and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Annemette Thougaard

30 papers receiving 1.1k citations

Peers

Annemette Thougaard
Dong Hu Australia
Sudha Iyer United States
Do‐Sim Park South Korea
Dae‐Myung Jue South Korea
Annemette Thougaard
Citations per year, relative to Annemette Thougaard Annemette Thougaard (= 1×) peers Weirong Wang

Countries citing papers authored by Annemette Thougaard

Since Specialization
Citations

This map shows the geographic impact of Annemette Thougaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annemette Thougaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annemette Thougaard more than expected).

Fields of papers citing papers by Annemette Thougaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annemette Thougaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annemette Thougaard. The network helps show where Annemette Thougaard may publish in the future.

Co-authorship network of co-authors of Annemette Thougaard

This figure shows the co-authorship network connecting the top 25 collaborators of Annemette Thougaard. A scholar is included among the top collaborators of Annemette Thougaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annemette Thougaard. Annemette Thougaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wegener, Karen Malene, Steen Larsen, Lassina Badolo, et al.. (2018). PFE-360-induced LRRK2 inhibition induces reversible, non-adverse renal changes in rats. Toxicology. 395. 15–22. 42 indexed citations
3.
Thirstrup, Kenneth, et al.. (2015). Linking HSP90 target occupancy to HSP70 induction and efficacy in mouse brain. Pharmacological Research. 104. 197–205. 19 indexed citations
4.
Hornberg, Jorrit J., et al.. (2013). Exploratory toxicology as an integrated part of drug discovery. Part I: Why and how. Drug Discovery Today. 19(8). 1131–1136. 78 indexed citations
5.
Langer, Seppo W., Annemette Thougaard, Maxwell Sehested, & Peter Buhl Jensen. (2011). Treatment of experimental extravasation of amrubicin, liposomal doxorubicin, and mitoxantrone with dexrazoxane. Cancer Chemotherapy and Pharmacology. 69(2). 573–576. 12 indexed citations
6.
Thougaard, Annemette, Seppo W. Langer, Bo Hainau, et al.. (2010). A murine experimental anthracycline extravasation model: Pathology and study of the involvement of topoisomerase II alpha and iron in the mechanism of tissue damage. Toxicology. 269(1). 67–72. 10 indexed citations
7.
Jakobsen, Carl-Johan, et al.. (2010). Ketamine reduce left ventricular systolic and diastolic function in patients with ischaemic heart disease. Acta Anaesthesiologica Scandinavica. 54(9). 1137–1144. 24 indexed citations
8.
Nahimana, Aimable, Antoine Attinger, Christopher R. Ireson, et al.. (2009). The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies. Blood. 113(14). 3276–3286. 150 indexed citations
9.
Martin, Elke, Annemette Thougaard, Morten Grauslund, et al.. (2008). Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy. Toxicology. 255(1-2). 72–79. 76 indexed citations
10.
Grauslund, Morten, Annemette Thougaard, Annette Füchtbauer, et al.. (2007). A Mouse Model for Studying the Interaction of Bisdioxopiperazines with Topoisomerase IIα in Vivo. Molecular Pharmacology. 72(4). 1003–1014. 17 indexed citations
11.
Qian, Xiaozhong, William J. LaRochelle, Gulshan Ara, et al.. (2006). Activity of PXD101, a histone deacetylase inhibitor, in preclinical ovarian cancer studies. Molecular Cancer Therapeutics. 5(8). 2086–2095. 117 indexed citations
12.
Thougaard, Annemette, Christian Ensinger, Claus Høgdall, et al.. (2006). Tetranectin in cerebrospinal fluid of patients with multiple sclerosis. Scandinavian Journal of Clinical and Laboratory Investigation. 66(7). 577–584. 12 indexed citations
13.
Tumber, Anthony, Laura S. Collins, Kamille Dumong Petersen, et al.. (2006). The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo. Cancer Chemotherapy and Pharmacology. 60(2). 275–283. 68 indexed citations
14.
Thougaard, Annemette, Christian Ensinger, Claus Høgdall, et al.. (2005). Tetranectin in cerebrospinal fluid: Biochemical characterisation and evidence of intrathecal synthesis or selective uptake into CSF. Clinica Chimica Acta. 359(1-2). 65–71. 12 indexed citations
15.
Hofland, Kenneth Francis, Annemette Thougaard, Maxwell Sehested, & Peter Buhl Jensen. (2005). Dexrazoxane Protects against Myelosuppression from the DNA Cleavage–Enhancing Drugs Etoposide and Daunorubicin but not Doxorubicin. Clinical Cancer Research. 11(10). 3915–3924. 41 indexed citations
16.
Stege, Helle, Flemming Bager, E Jacobsen, & Annemette Thougaard. (2003). VETSTAT—the Danish system for surveillance of the veterinary use of drugs for production animals. Preventive Veterinary Medicine. 57(3). 105–115. 130 indexed citations
17.
Thougaard, Annemette, et al.. (2001). Tetranectin-like protein in vertebrate serum: a comparative immunochemical analysis. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 128(4). 625–634. 2 indexed citations
18.
Thougaard, Annemette, et al.. (1999). Correlation between α1‐Acid Glycoprotein and Total Sialic Acid in Serum from Dogs with Tumours. Journal of Veterinary Medicine Series A. 46(4). 231–237. 18 indexed citations
19.
Thougaard, Annemette, et al.. (1998). Determination of serum tetranectin: technical and clinical evaluation of three sandwich immunoassays. Clinica Chimica Acta. 276(1). 19–34. 5 indexed citations
20.
Thougaard, Annemette, et al.. (1994). Evaluation of an automated spectrophotometric assay for the determination of total sialic acid in canine serum. Veterinary Research Communications. 18(5). 337–345. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026